Merck Becomes One of the First CDMOs to Provide Full Viral Vec...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
DARMSTADT, Germany, Aug. 9, 2022 /PRNewswire-AsiaNet/ -- -- Reduces process development time by an estimated 40 percent -- Enables biopharmaceutical companies to increase the speed to clinicalmanufacturing -- Adds to company's best-in-class VirusExpress(R) Lentiviral Production ...
Authors: LATEST ASIANET NEWS RELEASES